BACKGROUND: Bone mineral density (BMD) is lower in amenorrheic athletes (AA) compared with eumenorrheic athletes (EA). Decreased energy availability and altered levels of appetite regulating hormones (ghrelin and leptin) in AA contribute to hypogonadism, an important cause of low BMD. The role of other nutritionally regulated hormones such as peptide YY (PYY) and adiponectin in mediating gonadal status and bone metabolism remains to be determined. OBJECTIVES: Our objective was to determine whether PYY and adiponectin are higher in AA compared with EA and contribute to hypogonadism and impaired bone metabolism in AA. METHODS: We determined PYY and adiponectin in 16 AA, 15 EA and 16 non-athletic controls 12-18 years old, and other nutritionally dependent hormones including ghrelin, leptin and IGF-1. We also measured testosterone, estradiol, PINP and NTX (markers of bone formation and resorption) and BMD. RESULTS: PYY was higher in AA than EA (111+/-52 vs. 61+/-29 pg/ml, p<0.05), whereas adiponectin did not differ between groups. Although activity scores did not differ, BMI was lower in AA than EA and a larger proportion (62.5% vs. 6.7%) reported disordered eating, indicating lower energy availability. PYY and adiponectin were independent predictors of testosterone in a regression model (p=0.01 and 0.04), but did not predict estradiol. PYY, but not adiponectin, was an independent and negative predictor of PINP (p=0.002) and lumbar bone mineral apparent density Z-scores (p=0.045) in this model. CONCLUSION: High PYY levels (but not adiponectin) differentiate AA from EA, and may be an important factor contributing to low bone density in athletes.
BACKGROUND: Bone mineral density (BMD) is lower in amenorrheic athletes (AA) compared with eumenorrheic athletes (EA). Decreased energy availability and altered levels of appetite regulating hormones (ghrelin and leptin) in AA contribute to hypogonadism, an important cause of low BMD. The role of other nutritionally regulated hormones such as peptide YY (PYY) and adiponectin in mediating gonadal status and bone metabolism remains to be determined. OBJECTIVES: Our objective was to determine whether PYY and adiponectin are higher in AA compared with EA and contribute to hypogonadism and impaired bone metabolism in AA. METHODS: We determined PYY and adiponectin in 16 AA, 15 EA and 16 non-athletic controls 12-18 years old, and other nutritionally dependent hormones including ghrelin, leptin and IGF-1. We also measured testosterone, estradiol, PINP and NTX (markers of bone formation and resorption) and BMD. RESULTS:PYY was higher in AA than EA (111+/-52 vs. 61+/-29 pg/ml, p<0.05), whereas adiponectin did not differ between groups. Although activity scores did not differ, BMI was lower in AA than EA and a larger proportion (62.5% vs. 6.7%) reported disordered eating, indicating lower energy availability. PYY and adiponectin were independent predictors of testosterone in a regression model (p=0.01 and 0.04), but did not predict estradiol. PYY, but not adiponectin, was an independent and negative predictor of PINP (p=0.002) and lumbar bone mineral apparent density Z-scores (p=0.045) in this model. CONCLUSION: High PYY levels (but not adiponectin) differentiate AA from EA, and may be an important factor contributing to low bone density in athletes.
Authors: D A Keire; P Mannon; M Kobayashi; J H Walsh; T E Solomon; J R Reeve Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-07 Impact factor: 4.052
Authors: Paul A Baldock; Amanda Sainsbury; Michelle Couzens; Ronaldo F Enriquez; Gethin P Thomas; Edith M Gardiner; Herbert Herzog Journal: J Clin Invest Date: 2002-04 Impact factor: 14.808
Authors: Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Pediatrics Date: 2002-01 Impact factor: 7.124
Authors: L Lenchik; T C Register; F C Hsu; K Lohman; B J Nicklas; B I Freedman; C D Langefeld; J J Carr; D W Bowden Journal: Bone Date: 2003-10 Impact factor: 4.398
Authors: Madhusmita Misra; Karen K Miller; Jennifer Bjornson; Annie Hackman; Avichal Aggarwal; Joyce Chung; Melissa Ott; David B Herzog; Michael L Johnson; Anne Klibanski Journal: J Clin Endocrinol Metab Date: 2003-12 Impact factor: 5.958
Authors: Katherine E Wortley; Karen Garcia; Haruka Okamoto; Karen Thabet; Keith D Anderson; Victor Shen; Jim P Herman; David Valenzuela; George D Yancopoulos; Matthias H Tschöp; Andrew Murphy; Mark W Sleeman Journal: Gastroenterology Date: 2007-08-15 Impact factor: 22.682
Authors: Corrine K Welt; Jean L Chan; John Bullen; Robyn Murphy; Patricia Smith; Alex M DePaoli; Aspasia Karalis; Christos S Mantzoros Journal: N Engl J Med Date: 2004-09-02 Impact factor: 91.245
Authors: Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom Journal: N Engl J Med Date: 2003-09-04 Impact factor: 91.245
Authors: I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly Journal: J Clin Invest Date: 2002-10 Impact factor: 14.808
Authors: Aidi Niu; Thomas O Carpenter; Jayleen M Grams; Shahab Bozorgmehri; Steven M Tommasini; Anne L Schafer; Benjamin K Canales Journal: Bone Date: 2019-06-19 Impact factor: 4.398
Authors: Kathryn E Ackerman; Melissa Putman; Gabriela Guereca; Alexander P Taylor; Lisa Pierce; David B Herzog; Anne Klibanski; Mary Bouxsein; Madhusmita Misra Journal: Bone Date: 2012-08-02 Impact factor: 4.398
Authors: Trent Stellingwerff; Ida A Heikura; Romain Meeusen; Stéphane Bermon; Stephen Seiler; Margo L Mountjoy; Louise M Burke Journal: Sports Med Date: 2021-06-28 Impact factor: 11.136